News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Lim Jonathan E
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
4
| Lim Jonathan E (Chairman & CEO) has filed a Form 4 on Erasca, Inc.
Txns:
| Bought 1,000,000 shares
@ $2.026, valued at
$2M
|
|
06/08/2023 |
4
| Lim Jonathan E (Chairman & CEO) has filed a Form 4 on Erasca, Inc.
Txns:
| Bought 100,000 shares
@ $2.75, valued at
$275k
|
|
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
4
| Lim Jonathan E (Chairman & CEO) has filed a Form 4 on Erasca, Inc.
Txns:
| Granted 1,500,000 options to buy
@ $4, valued at
$6M
|
|
01/10/2023 |
4
| Lim Jonathan E (Chairman & CEO) has filed a Form 4 on Erasca, Inc.
Txns:
| Bought 60,000 shares
@ $3.857, valued at
$231.4k
|
|
12/15/2022 |
4
| Lim Jonathan E (Chairman & CEO) has filed a Form 4 on Erasca, Inc.
Txns:
| Bought 40,000 shares
@ $4.99, valued at
$199.6k
|
|
02/03/2022 |
4
| Lim Jonathan E (Chairman & CEO) has filed a Form 4 on Erasca, Inc.
Txns:
| Granted 791,000 options to buy
@ $11.54, valued at
$9.1M
|
|
07/20/2021 |
4
| Lim Jonathan E (See Remarks) has filed a Form 4 on Erasca, Inc.
Txns:
| Converted 5,135,390 shares
@ $0 Converted 5,441,027 shares
@ $0 Converted 6,162,468 preferred shares
@ $0 Converted 6,081,233 preferred shares
@ $0 Converted 336,000 preferred shares
@ $0 Converted 112,000 preferred shares
@ $0 |
|
07/15/2021 |
3
| Lim Jonathan E (See Remarks) has filed a Form 3 on Erasca, Inc. |
02/12/2018 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Disposed/sold 179,661 shares
@ $27, valued at
$4.9M
Disposed/sold 3,350,000 shares
@ $27, valued at
$90.5M
Disposed/sold 400,000 options to buy
@ $6, valued at
$2.4M
Disposed/sold 100,000 options to buy
@ $6.58, valued at
$658k
Disposed/sold 120,000 options to buy
@ $5.6, valued at
$672k
|
|
12/28/2017 |
4
| Lim Jonathan E (President, CEO and Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Paid exercise price by delivering 19,006 shares
@ $26.7, valued at
$507.5k
|
|
12/27/2017 |
4/A
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Granted 68,334 shares
@ $0 |
|
12/22/2017 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Granted 68,334 shares
@ $0 |
|
03/10/2017 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc. |
01/06/2017 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc. |
04/13/2016 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Exercised 26,388 options to buy
@ $0.6, valued at
$15.8k
|
|
03/21/2016 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Bought 24,852 shares
@ $5.5078, valued at
$136.9k
|
|
01/11/2016 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Granted 72,000 shares
@ $0 |
|
08/21/2015 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Bought 6,500 shares
@ $12.9518, valued at
$84.2k
Bought 240 shares
@ $13.05, valued at
$3.1k
Bought 1,700 shares
@ $12.6899, valued at
$21.6k
Bought 40 shares
@ $12.7672, valued at
$510.7 |
|
03/24/2015 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Bought 20,000 shares
@ $9.01, valued at
$180.2k
|
|
01/09/2015 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Granted 100,000 options to buy
@ $6.58, valued at
$658k
|
|
08/19/2014 |
4
| Lim Jonathan E (President, CEO & Director) has filed a Form 4 on Ignyta, Inc.
Txns:
| Bought 5,000 shares
@ $7.5994, valued at
$38k
|
|
02/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/14/2010 |
4
| Lim Jonathan E (CEO) has filed a Form 4 on HALOZYME THERAPEUTICS INC
Txns:
| Exercised 30,000 options to buy
@ $0.39, valued at
$11.7k
|
|
02/08/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
|
|